Showing 1,821 - 1,840 results of 55,856 for search '(( 5 ((ng decrease) OR (we decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 1.30s Refine Results
  1. 1821
  2. 1822
  3. 1823
  4. 1824
  5. 1825
  6. 1826
  7. 1827

    S2 File - by Shaban Gul (14309526)

    Published 2022
    Subjects:
  8. 1828
  9. 1829
  10. 1830
  11. 1831
  12. 1832
  13. 1833

    S1 File - by Shaban Gul (14309526)

    Published 2022
    Subjects:
  14. 1834
  15. 1835
  16. 1836

    Image 2_Probiotic Limosilactobacillus reuteri KUB-AC5 decreases urothelial cell invasion and enhances macrophage killing of uropathogenic Escherichia coli in vitro study.tiff by Arishabhas Tantibhadrasapa (13929639)

    Published 2024
    “…However, the antibacterial and immune modulatory effects of AC5 on UPEC have never been explored.</p>Methods<p>Here, we investigated both the direct and indirect effects of AC5 against UPEC isolates (UTI89, CFT073, and clinical MDR UPEC AT31) in vitro. …”
  17. 1837

    Table 1_Probiotic Limosilactobacillus reuteri KUB-AC5 decreases urothelial cell invasion and enhances macrophage killing of uropathogenic Escherichia coli in vitro study.xlsx by Arishabhas Tantibhadrasapa (13929639)

    Published 2024
    “…However, the antibacterial and immune modulatory effects of AC5 on UPEC have never been explored.</p>Methods<p>Here, we investigated both the direct and indirect effects of AC5 against UPEC isolates (UTI89, CFT073, and clinical MDR UPEC AT31) in vitro. …”
  18. 1838

    Image 1_Probiotic Limosilactobacillus reuteri KUB-AC5 decreases urothelial cell invasion and enhances macrophage killing of uropathogenic Escherichia coli in vitro study.tiff by Arishabhas Tantibhadrasapa (13929639)

    Published 2024
    “…However, the antibacterial and immune modulatory effects of AC5 on UPEC have never been explored.</p>Methods<p>Here, we investigated both the direct and indirect effects of AC5 against UPEC isolates (UTI89, CFT073, and clinical MDR UPEC AT31) in vitro. …”
  19. 1839
  20. 1840

    Effect of 10 ng of IL-1β and IL-1Ra in a preliminary recording of the LFPs in the OB. by Adriana Jiménez (3551204)

    Published 2025
    “…<p>A) A single dose of 10 ng of IL-1β decreased the amplitude of LFPs in the OB immediately after its microinjection, reaching a maximum effect at approximately 10 min and remaining constant for at least 45 min. …”